Incidex Healthcare (I) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 25 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Ebitda 76.05%
- Net Worth -16.42%
- Total Assets -1.09%
About Incidex Healthcare (I)
Incidex Healthcare (I) Private Limited (IHIPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 June 1999 and has a history of 25 years and seven months. Its registered office is in Na, Haryana.
The Corporate was formerly known as Photay Servces (India)Private Limited. The Company is engaged in the Transport And Logistics Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Harbans Singh, Parkash Photay, and Narinder Singh serve as directors at the Company.
Company Details
-
LocationNa, Haryana
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U63040HR1999PTC034278
-
Company No.
034278
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Jun 1999
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Incidex Healthcare (I)?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harbans Singh
|
Director | 06-Aug-2004 | Current |
Parkash Photay
|
Director | 22-Jun-1999 | Current |
|
Narinder Singh
|
Director | 30-Sep-2019 | Current |
Financial Performance of Incidex Healthcare (I).
Incidex Healthcare (I) Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 16.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Incidex Healthcare (I)?
In 2019, Incidex Healthcare (I) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
D.C.L. Dencare India Pvt LtdHarbans Singh, Parkash Photay and 1 more are mutual person
-
Psp Research India Private LimitedHarbans Singh, Parkash Photay and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Incidex Healthcare (I)?
Unlock and access historical data on people associated with Incidex Healthcare (I), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Incidex Healthcare (I), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Incidex Healthcare (I)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
